Trials / Completed
CompletedNCT04415866
Generalized Hypersensitivity in Patients With Fibromyalgia Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of Florida · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Fibromyalgia (FM) is a chronic musculoskeletal pain disorder with unknown causes. Our previous studies showed abnormal sensations of second pain (wind-up), indicating central hypersensitivity as an important mechanism of FM. Triggering events have been implicated as the cause of central hypersensitivity.
Detailed description
Increasing evidence has shown that the hypersensitivity of FM is not limited to painful stimuli but seems to extend to non-painful stimuli as well. These stimuli include smell, taste, touch, light, and sound. This study will provide detailed QST examinations of FM subjects and controls' responses to light using visually evoked potentials (VEP). In addition, careful characterization of experimental pain responding across multiple sensory modalities will be examined.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Paced Auditory Serial Addition task (PASAT) | Single and double digits are presented at intervals between 2 and 3 seconds and the participant must add each new digit to the one immediately prior to it. The participants will be asked to indicate by electronic button press whether the sum of the addition is 13 or not. The duration of the PASAT will be two 12-min tasks. |
Timeline
- Start date
- 2020-08-28
- Primary completion
- 2020-12-11
- Completion
- 2020-12-11
- First posted
- 2020-06-04
- Last updated
- 2025-03-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04415866. Inclusion in this directory is not an endorsement.